Author:
Ramachandran Vignesh,Rosen Ted,Koshelev Misha,Sandoval Fareesa Shuja
Publisher
Springer International Publishing
Reference91 articles.
1. Dogra S, Mahajan R. Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring. Indian Dermatol Online J. 2016;7(6):471–80.
2. Schlager JG, Rosumeck S, Werner RN, Jacobs A, Schmitt J, Schlager C, Nast A. Topical treatments for scalp psoriasis. Cochrane Database Syst Rev. 2016 Feb 26;2:CD009687.
3. Le Moigne M, Sommet A, Lapeyre-Mestre M, Bourrel R, Molinier L, Paul C, Montastruc JL. Healthcare cost impact of biological drugs compared with traditional systemic treatments in psoriasis: a cohort analysis in the French insurance database. J Eur Acad Dermatol Venereol. 2014 Sep;28(9):1235–44.
4. Soriatane [package insert]. Coral Gables: Stiefel Laboratories, Inc; 2011.
5. Hydrea (hydroxyurea). Food and Drug Administration. Accessed at https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/016295Orig1s047,s048Lbl.pdf. March 2016. Retrieved on June 28, 2019.